BMY•benzinga•
Bristol Myers Unveils Positive Phase 3 Results for Sotyktu in Psoriatic Arthritis
Summary
Bristol Myers Squibb's Phase 3 POETYK PsA-2 trial shows Sotyktu improved psoriatic arthritis symptoms, meeting primary and secondary endpoints at Week 16.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 10, 2025 by benzinga